A Study to Evaluate the Effect of [14C]Acp-196 (Acalabrutinib) in Healthy Adult Participants

Trial Identifier:	ACE-HV-009
Sponsor:	Acerta Pharma BV
NCTID::	NCT04898101
Start Date:	March 2016
Primary Completion Date:	April 2016
Study Completion Date:	April 2016
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States, Wisconsin	Madison, Wisconsin, United States, 53704

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.